About QAWaCh Bio
QAWaCh Bio is a company based in Navi Mumbai (India) founded in 2018 by Kunal and Mohan Singh. QAWaCh Bio offers products and services including InstaNGAL®, InstaCOVID Ag, Uncut Sheets & Reagents, and Product Development Services. QAWaCh Bio operates in a competitive market with competitors including Curative, SphingoTec, Proteomics International, Pictor and Astute Medical, among others.
- Headquarter Navi Mumbai, India
- Founders Kunal, Mohan Singh
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Qawach Bio Private Limited
- Date of Incorporation 24 May, 2018
- Jurisdiction Navi Mumbai, Maharashtra, India
-
Annual Revenue
$7.97 K (USD)0as on Mar 31, 2020
-
Net Profit
-$8.37 K (USD)-2345.85as on Mar 31, 2020
-
EBITDA
-$15.27 K (USD)-4363.75as on Mar 31, 2020
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of QAWaCh Bio
QAWaCh Bio offers a comprehensive portfolio of products and services, including InstaNGAL®, InstaCOVID Ag, Uncut Sheets & Reagents, and Product Development Services.
Quantitative test kit for early biomarker detection in healthcare.
Rapid antigen test for detecting COVID-19 infections.
Materials to enhance sensitivity in rapid test kits.
Assistance in developing and improving IVD-based products.
Funding Insights of QAWaCh Bio
Detailed funding history for QAWaCh Bio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by QAWaCh Bio
Investment portfolio details for QAWaCh Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - QAWaCh Bio
Detailed financials for QAWaCh Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Qawach Bio Comparisons
Peer comparison for QAWaCh Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of QAWaCh Bio
QAWaCh Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curative, SphingoTec, Proteomics International, Pictor and Astute Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Curative is recognized for providing affordable employer-sponsored health insurance.
|
|
| Locked | Locked | Locked |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed.
|
|
| Locked | Locked | Locked |
Medical technology company at the forefront of predictive diagnostics and bio-analytical services
|
|
| Locked | Locked | Locked |
Immunodiagnostic products are developed via multiplexed assays.
|
|
| Locked | Locked | Locked |
Biomarkers are identified for diagnosing high-risk medical conditions.
|
|
| Locked | Locked | Locked |
CRISPR-based COVID-19 molecular testing devices are manufactured.
|
Detailed competitors of QAWaCh Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Qawach Bio
Complete news archive for QAWaCh Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about QAWaCh Bio
QAWaCh Bio was founded in 2018.
QAWaCh Bio is headquartered in Navi Mumbai, India. It is registered at Navi Mumbai, Maharashtra, India.
Annual revenue of QAWaCh Bio is $7.97K as on Mar 31, 2020.
Developer of rapid diagnostic test kits for the detection kidney and infectious diseases. The companys products include InstaNGAL is a quantitative bedside test kit that is intended for early diagnosis of acute kidney injury and InstaCOVID Ag is a qualitative rapid antigen test kit for COVID-19 detection.
QAWaCh Bio's top competitors include Curative, SphingoTec and Pictor.
QAWaCh Bio offers InstaNGAL®, InstaCOVID Ag, Uncut Sheets & Reagents, and Product Development Services.